Browse Category

Investment News News 15 October 2025 - 16 October 2025

Femasys (FEMY) Stock Soars 46% on Fertility Tech and FDA Milestones

Femasys (FEMY) Stock Soars 46% on Fertility Tech and FDA Milestones

Femasys’ stock surge on Oct. 16 mirrors growing investor interest in its reproductive healthcare pipeline. The company’s FemaSeed™ technology is designed to boost pregnancy rates by delivering sperm directly into the fallopian tube, and published trials report more than double the pregnancy
J.B. Hunt (JBHT) Stock Soars on Earnings Surprise – Is a Freight Sector Revival Underway?

J.B. Hunt (JBHT) Stock Soars on Earnings Surprise – Is a Freight Sector Revival Underway?

Stock Rally After Earnings Beat J.B. Hunt’s stock rallied hard on Oct. 16. Reuters reported that JBHT shares “rose nearly 16% in early trading on Thursday” (Oct 16) after the company’s cost-cutting drove a stronger-than-expected profit reuters.com. Traders noted a
Linkage Global (LGCB) Stock Doubles on Funding Lifeline – Can the E-Commerce Underdog Sustain the Rally?

Linkage Global (LGCB) Stock Doubles on Funding Lifeline – Can the E-Commerce Underdog Sustain the Rally?

Stock Price Volatility Amid Funding News Linkage Global’s stock has been on a rollercoaster, catapulting upward in recent sessions. On Thursday Oct. 16, LGCB nearly doubled in pre-market action, reaching around $3 per share stockanalysis.com. This spike followed an after-hours
Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Novo Nordisk Licensing Deal Sparks Rally On Oct. 15, Novo Nordisk (NYSE: NVO) and Omeros announced a landmark deal licensing zaltenibart (OMS906), Omeros’s experimental MASP-3 inhibitor for rare blood/kidney diseases investor.omeros.com. Under the agreement, Novo pays $340M upfront and can
1 61 62 63 64 65 68
Go toTop